Mirabaud Asset Management (France) SAS
Follow13F filer, CIK 2033031, PARIS, France
Mirabaud Asset Management (France) SAS reported $86,098,705 across 9 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002033031-25-000001
- Period
- 2024-12-31
- Reported value
- $86.1M
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 6
- Sold out
- 3
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0002033031-25-000001, largest first. % of portfolio is the value over $86,098,705, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| LI AUTO INCLI AUTO INC NOTE 0.250% 5/0 | principal | 14,450,000 | $16.7M | -2,400,000 |
| EQUINOX GOLD CORPEQUINOX GOLD CORP NOTE 4.750%10/1 | principal | 14,820,000 | $16.4M | new |
| RAPID7 INCRAPID7 INC NOTE 1.250% 3/1 | principal | 12,100,000 | $11.7M | new |
| HALOZYME THERAPEUTICS INCHALOZYME THERAPEUTICS INC NOTE 1.000% 8/1 | principal | 7,950,000 | $8.63M | new |
| SEAGATE HDD CAYMANSEAGATE HDD CAYMAN NOTE 3.500% 6/0 | principal | 6,700,000 | $8.14M | new |
| AKAMAI TECHNOLOGIES INCAKAMAI TECHNOLOGIES INC NOTE 0.125% 5/0 | principal | 7,500,000 | $7.99M | +1,500,000 |
| ALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INC NOTE 1.000% 9/1 | principal | 5,200,000 | $5.57M | new |
| WAYFAIR INCWAYFAIR INC NOTE 3.250% 9/1 | principal | 5,100,000 | $5.51M | -11,900,000 |
| CYTOKINETICS INCCYTOKINETICS INC NOTE 3.500% 7/0 | principal | 4,500,000 | $5.49M | new |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| LIVE NATION ENTERTAINMENT INLIVE NATION ENTERTAINMENT IN | 8,500,000 | $10.5M | principal |
| LIBERTY MEDIA CORP DELLIBERTY MEDIA CORP DEL | 9,200,000 | $10.2M | principal |
| NUTANIX INCNUTANIX INC | 5,500,000 | $6.61M | principal |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002033031-25-000001 | base | 2025-02-13 | acceptance time not in the bulk data set |